Cargando…

Prevalence of medication discrepancies in patients with cirrhosis: a pilot study

BACKGROUND: Cirrhosis patients are prescribed multiple medications for their liver disease and comorbidities. Discrepancies between medicines consumed by patients and those documented in the medical record may contribute to patient harm and impair disease management. The aim of the present study was...

Descripción completa

Detalles Bibliográficos
Autores principales: Hayward, Kelly L., Valery, Patricia C., Cottrell, W. Neil, Irvine, Katharine M., Horsfall, Leigh U., Tallis, Caroline J., Chachay, Veronique S., Ruffin, Brittany J, Martin, Jennifer H., Powell, Elizabeth E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5020443/
https://www.ncbi.nlm.nih.gov/pubmed/27618841
http://dx.doi.org/10.1186/s12876-016-0530-4
_version_ 1782453202149441536
author Hayward, Kelly L.
Valery, Patricia C.
Cottrell, W. Neil
Irvine, Katharine M.
Horsfall, Leigh U.
Tallis, Caroline J.
Chachay, Veronique S.
Ruffin, Brittany J
Martin, Jennifer H.
Powell, Elizabeth E.
author_facet Hayward, Kelly L.
Valery, Patricia C.
Cottrell, W. Neil
Irvine, Katharine M.
Horsfall, Leigh U.
Tallis, Caroline J.
Chachay, Veronique S.
Ruffin, Brittany J
Martin, Jennifer H.
Powell, Elizabeth E.
author_sort Hayward, Kelly L.
collection PubMed
description BACKGROUND: Cirrhosis patients are prescribed multiple medications for their liver disease and comorbidities. Discrepancies between medicines consumed by patients and those documented in the medical record may contribute to patient harm and impair disease management. The aim of the present study was to assess the magnitude and types of discrepancies among patient-reported and medical record-documented medications in patients with cirrhosis, and examine factors associated with such discrepancies. METHODS: Fifty patients who attended a hospital hepatology outpatient clinic were interviewed using a questionnaire composed of mixed short-response and multiple-choice questions. Patients’ reported medication use was compared with documentation in the hospital medical records and pharmacy database. Medication adherence was assessed using the 8-question ©Morisky Medication Adherence Scale (MMAS-8). The multivariate logistic regression model was constructed using clinically relevant and/or statistically significant variables as determined by univariate analysis. All p-values were 2-sided (α = 0.05). RESULTS: Twenty-seven patients (54.0 %) had ≥1 discrepancy between reported and documented medicines. Patients with ≥1 discrepancy were older (p = 0.04) and multivariate analysis identified taking ≥5 conventional medicines or having a ‘low’ or ‘medium’ adherence ranking as independent predictors of discrepancy (adjusted OR 11.0 (95 % CI 1.8–67.4), 20.7 (95 % CI 1.3–337.7) and 49.0 (95 % CI 3.3–718.5) respectively). Concordance was highest for liver disease medicines (71.9 %) and lowest for complementary and alternative medicines (14.5 %) and respiratory medicines (0 %). CONCLUSION: There is significant discrepancy between sources of patient medication information within the hepatology clinic. Medication reconciliation and medicines-management intervention may address the complex relationship between medication discrepancies, number of medications and patient adherence identified in this study.
format Online
Article
Text
id pubmed-5020443
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-50204432016-09-14 Prevalence of medication discrepancies in patients with cirrhosis: a pilot study Hayward, Kelly L. Valery, Patricia C. Cottrell, W. Neil Irvine, Katharine M. Horsfall, Leigh U. Tallis, Caroline J. Chachay, Veronique S. Ruffin, Brittany J Martin, Jennifer H. Powell, Elizabeth E. BMC Gastroenterol Research Article BACKGROUND: Cirrhosis patients are prescribed multiple medications for their liver disease and comorbidities. Discrepancies between medicines consumed by patients and those documented in the medical record may contribute to patient harm and impair disease management. The aim of the present study was to assess the magnitude and types of discrepancies among patient-reported and medical record-documented medications in patients with cirrhosis, and examine factors associated with such discrepancies. METHODS: Fifty patients who attended a hospital hepatology outpatient clinic were interviewed using a questionnaire composed of mixed short-response and multiple-choice questions. Patients’ reported medication use was compared with documentation in the hospital medical records and pharmacy database. Medication adherence was assessed using the 8-question ©Morisky Medication Adherence Scale (MMAS-8). The multivariate logistic regression model was constructed using clinically relevant and/or statistically significant variables as determined by univariate analysis. All p-values were 2-sided (α = 0.05). RESULTS: Twenty-seven patients (54.0 %) had ≥1 discrepancy between reported and documented medicines. Patients with ≥1 discrepancy were older (p = 0.04) and multivariate analysis identified taking ≥5 conventional medicines or having a ‘low’ or ‘medium’ adherence ranking as independent predictors of discrepancy (adjusted OR 11.0 (95 % CI 1.8–67.4), 20.7 (95 % CI 1.3–337.7) and 49.0 (95 % CI 3.3–718.5) respectively). Concordance was highest for liver disease medicines (71.9 %) and lowest for complementary and alternative medicines (14.5 %) and respiratory medicines (0 %). CONCLUSION: There is significant discrepancy between sources of patient medication information within the hepatology clinic. Medication reconciliation and medicines-management intervention may address the complex relationship between medication discrepancies, number of medications and patient adherence identified in this study. BioMed Central 2016-09-13 /pmc/articles/PMC5020443/ /pubmed/27618841 http://dx.doi.org/10.1186/s12876-016-0530-4 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Hayward, Kelly L.
Valery, Patricia C.
Cottrell, W. Neil
Irvine, Katharine M.
Horsfall, Leigh U.
Tallis, Caroline J.
Chachay, Veronique S.
Ruffin, Brittany J
Martin, Jennifer H.
Powell, Elizabeth E.
Prevalence of medication discrepancies in patients with cirrhosis: a pilot study
title Prevalence of medication discrepancies in patients with cirrhosis: a pilot study
title_full Prevalence of medication discrepancies in patients with cirrhosis: a pilot study
title_fullStr Prevalence of medication discrepancies in patients with cirrhosis: a pilot study
title_full_unstemmed Prevalence of medication discrepancies in patients with cirrhosis: a pilot study
title_short Prevalence of medication discrepancies in patients with cirrhosis: a pilot study
title_sort prevalence of medication discrepancies in patients with cirrhosis: a pilot study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5020443/
https://www.ncbi.nlm.nih.gov/pubmed/27618841
http://dx.doi.org/10.1186/s12876-016-0530-4
work_keys_str_mv AT haywardkellyl prevalenceofmedicationdiscrepanciesinpatientswithcirrhosisapilotstudy
AT valerypatriciac prevalenceofmedicationdiscrepanciesinpatientswithcirrhosisapilotstudy
AT cottrellwneil prevalenceofmedicationdiscrepanciesinpatientswithcirrhosisapilotstudy
AT irvinekatharinem prevalenceofmedicationdiscrepanciesinpatientswithcirrhosisapilotstudy
AT horsfallleighu prevalenceofmedicationdiscrepanciesinpatientswithcirrhosisapilotstudy
AT talliscarolinej prevalenceofmedicationdiscrepanciesinpatientswithcirrhosisapilotstudy
AT chachayveroniques prevalenceofmedicationdiscrepanciesinpatientswithcirrhosisapilotstudy
AT ruffinbrittanyj prevalenceofmedicationdiscrepanciesinpatientswithcirrhosisapilotstudy
AT martinjenniferh prevalenceofmedicationdiscrepanciesinpatientswithcirrhosisapilotstudy
AT powellelizabethe prevalenceofmedicationdiscrepanciesinpatientswithcirrhosisapilotstudy